EUVIMED · CrossrefZeitschrift
Therapeutic Advances in Hematology
ISSN 2040-6207 · SAGE Publications
Neueste Artikel
Effectiveness of recombinant factor IX Fc prophylaxis for the treatment of haemophilia B: A systematic review of real-world evidence
Stanozolol plus avatrombopag for chemoradiotherapy-associated secondary aplastic anemia: A single-center retrospective cohort study
Real-world acute myeloid leukemia outcomes during a decade of molecular diagnostic expansion and azacitidine plus venetoclax adoption in Thailand: A single-center implementation cohort
Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?
Effectiveness of caplacizumab in the first-line treatment for acquired thrombotic thrombocytopenic purpura: single center experience
Real-world efficacy and tolerability of ixazomib-based combination therapies in advanced multiple myeloma and other plasma cell neoplasms
Efficacy and safety of chimeric antigen receptor T-cell therapy in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis
Nine areas with outstanding challenges for hemophilia B research
BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study
Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France
Molecular genetics profiling of core-binding factor acute myeloid leukemia in pediatrics
Real-world outcomes of azacitidine plus venetoclax in acute myeloid leukemia: a multicenter retrospective cohort study from Thailand
Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea
Hematopoietic stem cell microtransplantation: current situation and challenges
Between Charybdis and Scylla—an Odyssey in AL amyloidosis: insights and learnings from a narrative review and case report series
Significance of whole-blood EBV DNA status in T/NK-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis
Treatment of multiple myeloma with selinexor: a review
Research advances on short-chain fatty acids in gastrointestinal acute graft- versus -host disease
Treatment of multiple myeloma: What is the impact on T-cell function?
Down syndrome-associated leukaemias: current evidence and challenges
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasms
Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion
Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in China and the United States
Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDS
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide
Immune dysregulation and potential targeted therapy in myelodysplastic syndrome
Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
EUVIMED